相关实验视频
Updated: Jul 9, 2025

10:43
Evaluating In Vitro DNA Damage Using Comet Assay
Published on: October 11, 2017
37.7K
特莫索洛米德的特定运输不会取代DNA修复介导的化学抵抗
Katayun Bahrami1, Jussi Kärkkäinen1, Sania Bibi2
1School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland.
概括
改善药物输送并不是有效治疗脑瘤化疗的主要障碍. 研究人员发现,虽然一种新的前药物 (TMZ-AA) 更好地进入癌细胞,但它仍然需要DNA修复抑制剂来最大限度地抑制生长,这表明需要新的药物设计策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 泰莫佐洛米德 (Temozolomide,简称TMZ) 是用于治疗诸如多形质母细胞瘤 (GBM) 等脑瘤的标准化疗.
- 化学抵抗,而不是药物输送,是TMZ长期临床疗效的主要限制.
- 此前,TMZ穿越血脑屏障 (BBB) 的能力及其化学稳定性一直受到质疑.
研究的目的:
- 为了研究一种L型氨基酸载体1 (LAT1) -利用TMZ (TMZ-AA) 的前药物来增强细胞积累和细胞毒性作用.
- 评估TMZ-AA在表达功能LAT1的癌细胞中的疗效,包括人类状细胞癌和质瘤细胞.
- 为了确定通过LAT1载体的改善传递是否会导致癌细胞死亡的增加.
主要方法:
- TMZ-LAT1前药物 (TMZ-AA) 的制备和表征.
- 与TMZ相比,TMZ-AA在LAT1表达癌细胞中的细胞积累的评估 (UT-SCC-42B,U-87MG).
- 在单独或与DNA修复抑制剂 (MGMT,BER,MMR) 结合使用TMZ-AA治疗后,评估细胞毒性和细胞活力.
主要成果:
- TMZ-AA在LAT1表达癌细胞 (UT-SCC-42B) 中表现出比TMZ更高的细胞积累.
- 增加TMZ-AA的细胞吸收与增强的癌细胞死亡没有相关性.
- 与TMZ相似的TMZ-AA最大增长抑制需要同时使用向DNA修复系统 (MGMT,BER) 和活性DNA不匹配修复 (MMR) 的抑制剂.
结论:
- 通过LAT1载体增强TMZ的输送不能克服化疗抵抗,也不是改善化疗的主要障碍.
- 针对LAT1这样的载体,虽然可能为BBB或质瘤细胞透提供优势,但并不能本质上提高药物的疗效.
- 未来的抗癌前药物开发应该专注于修改DNA化部位或抑制关键DNA修复通路,以获得更大的治疗效果.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Overview of DNA Repair
31.1K
In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Chemically...
31.1K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K

